Am Fam Physician. 2025;112(2):200-202
Author disclosure: No relevant financial relationships.
DETAILS FOR THIS REVIEW
Study Population: 39,991 patients with acute lower gastrointestinal (GI) bleeding from four independent cohorts
Efficacy End Points: Safe for hospital discharge, major bleeding, need for blood transfusion, need for hemostasis
Harm End Points: Not applicable
| Oakland Score > 8 |
| Major bleeding |
| Sensitivity: 97% (95% CI, 95%–99%) |
| Specificity: 9% (95% CI, 7%–12%) |
| Positive likelihood ratio: 1.07 |
| Blood transfusion |
| Sensitivity: 99% (95% CI, 99.1%–99.3%) |
| Specificity: 12% (95% CI, 9%–18%) |
| Positive likelihood ratio: 1.14 |
| Need for hemostasis |
| Sensitivity: 91% (95% CI, 81%–96%) |
| Specificity: 7% (95% CI, 4%–12%) |
| Positive likelihood ratio: 1.0 |
| Oakland Score ≤ 8 |
| Safe discharge |
| Sensitivity: 10% (95% CI, 5%–20%) |
| Specificity: 97% (95% CI, 95%–98%) |
| Negative likelihood ratio: 0.9 |
Already a member/subscriber?
Log In
Subscribe
From $180- Immediate, unlimited access to all AFP content
- More than 125 CME credits/year
- AAFP app access
- Print delivery available
Issue Access
$59.95- Immediate, unlimited access to this issue's content
- CME credits
- AAFP app access
- Print delivery available
Interested in AAFP membership?
Learn More
